News Moderna, Inc.

Equities

MRNA

US60770K1079

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2025-06-13 EDT			5-day change	1st Jan Change
26.67 ^USD	-2.49%		-2.88%	-35.86%

06-13	Moderna falls on doubts over new CDC panel's backing of RSV vaccine	RE
06-13	Moderna falls on doubts over new CDC panel's backing of RSV vaccine	RE

Moderna falls on doubts over new CDC panel's backing of RSV vaccine	06-13	RE
Moderna falls on doubts over new CDC panel's backing of RSV vaccine	06-13	RE
Global markets live: Tesla, Google, Apple, Novo Nordisk, Boeing…	06-13
Sector Update: Health Care Stocks Lean Lower Premarket Friday	06-13	MT
Sector Update: Health Care	06-13	MT
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday Amid Middle East Conflict	06-13	MT
Moderna: expanded indication for RSV vaccine	06-13	CF
GSK applies to EU regulator for expanded use of RSV vaccine	06-13	RE
Moderna Gets FDA Approval for mRESVIA in Adults Aged 18-59 at Increased Risk for RSV Disease	06-13	MT
US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults	06-12	RE
Moderna RSV Vaccine Gets Expanded FDA Approval, Company Says	06-12	DJ
US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults	06-12	RE
Moderna Says Received FDA Approval For RSV Vaccine, Mresvia, In Adults Aged 18-59 At Increased Risk For RSV Disease	06-12	RE
US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults	06-12	RE
Vaccine actions and policy positions under US Health Secretary Kennedy	06-12	RE
Sector Update: Health Care Stocks Advance in Afternoon Trading	06-12	MT
Moderna Seeks External Funding for Late-Stage Vaccine Trials	06-12	MT
Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025	06-12	AQ
Vaccine actions and policy positions under US Health Secretary Kennedy	06-12	RE
Kennedy replaces fired US CDC panel members, includes anti-vaccine proponents	06-12	RE
Kennedy replaces fired US CDC panel members, includes anti-vaccine proponents	06-11	RE
Moderna, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 08:40 AM	06-11
Novavax's COVID-flu combo vaccine shows strong immune response in trial	06-11	RE
Novavax's COVID-flu combo vaccine shows strong immune response in trial	06-11	RE
Wall Street ends higher as investors track US-China trade talks	06-10	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Moderna Reports Another Quarterly Loss

February 14, 2025 at 04:24 pm

Moderna, Inc. prepares for the post-Covid era

March 25, 2024 at 10:24 am